Cellular and molecular characterization of osteoclasts (OCL) has been extremely difficult since OCL are rare cells, and are difficult to isolate in large numbers. We used the tartrate-resistant acid phosphatase promoter to target the bcl-XL and/or Simian Virus 40 large T antigen (Tag) genes to cells in the OCL lineage in transgenic mice as a means of immortalizing OCL precursors. Immunocytochemical studies confirmed that we had targeted Bcl-XL and/or Tag to OCL, and transformed and mitotic OCL were readily apparent in bones from both Tag and bcl-XL/Tag mice. OCL formation in primary bone marrow cultures from bcl-XL, Tag, or bcl-XL/Tag mice was twofold greater compared with that of nontransgenic littermates. Bone marrow cells from bcl-XL/Tag mice, but not from singly transgenic bcl-XL or Tag mice, have survived in continuous culture for more than a year. These cells form high numbers of bone-resorbing OCL when cultured using standard conditions for inducing OCL formation, with approximately 50% of the mononuclear cells incorporated into OCL. The OCL that form express calcitonin receptors and contract in response to calcitonin. Studies examining the proliferative capacity and the resistance of OCL precursors from these transgenic mice to apoptosis demonstrated that the increased numbers of OCL precursors in marrow from bcl-XL/Tag mice was due to their increased survival rather than an increased proliferative capacity compared with Tag, bcl-XL, or normal mice. Histomorphometric studies of bones from bcl-XL/Tag mice also confirmed that there were increased numbers of OCL precursors (TRAP + mononuclear cells) present in vivo. These data demonstrate that by targeting both bcl-XL and Tag to cells in the OCL lineage, we have immortalized OCL precursors that form bone-resorbing OCL with an efficiency that is 300-500 times greater than that of normal marrow.
T A Hentunen, S V Reddy, B F Boyce, R Devlin, H R Park, H Chung, K S Selander, M Dallas, N Kurihara, D L Galson, S R Goldring, B A Koop, J J Windle, G D Roodman
Title and authors | Publication | Year |
---|---|---|
Positive and negative regulators of osteoclast apoptosis
NS Soysa, N Alles |
Bone Reports | 2019 |
FoxO1 Orchestrates the Bone Suppressing Function of Gut Serotonin
Aruna Kode, Ioanna Mosialou, Barbara C Silva, Marie-Therese Rached, Bin Zhou, Ji Wang, Tim Townes, Rene Hen, Ronald DePinho, Edward Guo, Stavroula Kousteni |
Journal of Clinical Investigation | 2012 |
Bone Research Protocols
MH Helfrich, SH Ralston |
2011 | |
Bone Research Protocols
MH Helfrich, SH Ralston |
2011 | |
Bone Research Protocols
MH Helfrich, SH Ralston |
2011 | |
Bone Research Protocols
MH Helfrich, SH Ralston |
2011 | |
Bone Research Protocols
MH Helfrich, SH Ralston |
2011 | |
Bone Research Protocols
MH Helfrich, SH Ralston |
2011 | |
Bim: Guardian of Tissue Homeostasis and Critical Regulator of the Immune System, Tumorigenesis and Bone Biology
T Akiyama, S Tanaka |
Archivum Immunologiae et Therapiae Experimentalis | 2011 |
Osteoclasts derived from patients with neurofibromatosis 1 (NF1) display insensitivity to bisphosphonates in vitro
E Heervä, S Peltonen, E Svedström, HT Aro, K Väänänen, J Peltonen |
Bone | 2011 |
Activating Transcription Factor 4 Regulates Osteoclast Differentiation
Huiling Cao, Shibing Yu, Zhi Yao, Deborah L. Galson, Yu Jiang, Xiaoyan Zhang, Jie Fan, Binfeng Lu, Youfei Guan, Min Luo, Yumei Lai, Yibei Zhu, Noriyoshi Kurihara, Kenneth Patrene, G. David Roodman, Guozhi Xiao |
Journal of Clinical Investigation | 2010 |
Genetic alterations in a telomerase-immortalized human esophageal epithelial cell line: Implications for carcinogenesis
PY Cheung, W Deng, C Man, WW Tse, G Srivastava, S Law, SW Tsao, AL Cheung |
Cancer Letters | 2010 |
ADAM8 Enhances Osteoclast Precursor Fusion and Osteoclast Formation In Vitro and In Vivo
H Ishizuka, V García-Palacios, G Lu, MA Subler, H Zhang, CS Boykin, SJ Choi, L Zhao, K Patrene, DL Galson, HC Blair, TM Hadi, JJ Windle, N Kurihara, GD Roodman |
Journal of Bone and Mineral Research | 2010 |
Vitamins & Hormones
KJ Hare, FK Knop |
Vitamins & Hormones | 2010 |
Negative regulation of bone-resorbing activity of osteoclasts by anti-apoptotic Bcl-xL protein
Mitsuyasu Iwasawa, Tsuyoshi Miyazaki, Yuichi Nagase, Toru Akiyama, Yuho Kadono, Masaki Nakamura, yasushi Oshima, Tetsuro Yasui, Takashi Nakamura, Shigeaki Kato, Lothar Hennighausen, Kozo Nakamura, Sakae Tanaka, Takumi Matsumoto |
Journal of Clinical Investigation | 2009 |
The Osteoblast, a Novel Site of Action for FoxO1 Regulation of Glucose Homeostasis
Marie-Therese Rached, Aruna Kode, Barbara C Silva, Dae Young Jung, Susan J Gray, Helena Ong, Ji-Hye Paik, Ronald A DePinho, Jason Kim, Gerard Karsenty, Stavroula Kousteni |
Journal of Clinical Investigation | 2009 |
Rac1 and Rac2 in Osteoclastogenesis: A Cell Immortalization Model
Y Wang, DD Belsham, M Glogauer |
Calcified Tissue International | 2009 |
Expression of macrophage inhibitory cytokine-1 in prostate cancer bone metastases induces osteoclast activation and weight loss
S Wakchoure, TM Swain, TA Hentunen, AR Bauskin, DA Brown, SN Breit, KS Vuopala, KW Harris, KS Selander |
The Prostate | 2009 |
Human osteoclasts differentiated from umbilical cord blood precursors are less prone to apoptotic stimuli than osteoclasts from peripheral blood
L Penolazzi, B Pocaterra, E Tavanti, E Lambertini, F Vesce, R Gambari, R Piva |
Apoptosis | 2008 |
Principles of Bone Biology
CJ Rosen, T Niu |
Principles of Bone Biology | 2008 |
Signaling Axis in Osteoclast Biology and Therapeutic Targeting in the RANKL/RANK/OPG System
S Tanaka |
American Journal of Nephrology | 2007 |
Bone Marrow Cell Differentiation Induced by Mechanically Damaged Osteocytes in 3D Gel-Embedded Culture
K Kurata, TJ Heino, H Higaki, HK Väänänen |
Journal of Bone and Mineral Research | 2006 |
Regulation of Osteoclast Differentiation
GD Roodman |
Annals of the New York Academy of Sciences | 2006 |
Molecular Mechanism of the Life and Death of the Osteoclast
S Tanaka |
Annals of the New York Academy of Sciences | 2006 |
Tumor necrosis factor prevents alendronate-induced osteoclast apoptosis in vivo by stimulating Bcl-xL expression through Ets-2
Q Zhang, IR Badell, EM Schwarz, KE Boulukos, Z Yao, BF Boyce, L Xing |
Arthritis & Rheumatism | 2005 |
Regulation of apoptosis in osteoclasts and osteoblastic cells
L Xing, BF Boyce |
Biochemical and Biophysical Research Communications | 2005 |
Role of RANKL in physiological and pathological bone resorption and therapeutics targeting the RANKL-RANK signaling system
S Tanaka, K Nakamura, N Takahasi, T Suda |
Immunological Reviews | 2005 |
IL-3 expression by myeloma cells increases both osteoclast formation and growth of myeloma cells
JW Lee, HY Chung, LA Ehrlich, DF Jelinek, NS Callander, GD Roodman, SJ Choi |
Blood | 2004 |
M-CSF, TNFalpha and RANK ligand promote osteoclast survival by signaling through mTOR/S6 kinase
H Glantschnig, JE Fisher, G Wesolowski, GA Rodan, AA Reszka |
Cell Death and Differentiation | 2003 |
Bcl-xL overexpression blocks bax-mediated mitochondrial contact site formation and apoptosis in rod photoreceptors of lead-exposed mice
L He, GA Perkins, AT Poblenz, JB Harris, M Hung, MH Ellisman, DA Fox |
Proceedings of the National Academy of Sciences | 2003 |
Eosinophil Chemotactic Factor-L (ECF-L): A Novel Osteoclast Stimulating Factor
Y Oba, HO Chung, SJ Choi, GD Roodman |
Journal of Bone and Mineral Research | 2003 |
Regulation of osteoclast apoptosis by ubiquitylation of proapoptotic BH3-only Bcl-2 family member Bim
T Akiyama |
The EMBO Journal | 2003 |
Mechanisms balancing skeletal matrix synthesis and degradation
HC Blair, M Zaidi, PH Schlesinger |
Biochemical Journal | 2002 |
Life is short, art long. Bcl-2 and osteoclast survival
H Glantschnig, AA Reszka |
BoneKEy-Osteovision | 2002 |
ADAM8: A Novel Osteoclast Stimulating Factor
SJ Choi, JH Han, GD Roodman |
Journal of Bone and Mineral Research | 2001 |
The Microphthalmia Transcription Factor Regulates Expression of the Tartrate-Resistant Acid Phosphatase Gene During Terminal Differentiation of Osteoclasts
A Luchin, G Purdom, K Murphy, MY Clark, N Angel, AI Cassady, DA Hume, MC Ostrowski |
Journal of Bone and Mineral Research | 2000 |
CFU-GM-Derived Cells Form Osteoclasts at a Very High Efficiency
C Menaa, N Kurihara, GD Roodman |
Biochemical and Biophysical Research Communications | 2000 |
Each Venture Is a New Beginning
MK Drezner |
Journal of Bone and Mineral Research | 2000 |
Transgenic Mice Overexpressing Tartrate-Resistant Acid Phosphatase Exhibit an Increased Rate of Bone Turnover
NZ Angel, N Walsh, MR Forwood, MC Ostrowski, AI Cassady, DA Hume |
Journal of Bone and Mineral Research | 2000 |
Structure, function, and regulation of tartrate-resistant acid phosphatase
GW Oddie, G Schenk, NZ Angel, N Walsh, LW Guddat, J Jersey, AI Cassady, SE Hamilton, DA Hume |
Bone | 2000 |
Rapid Screening Method for Osteoclast Differentiation in Vitro That Measures Tartrate-resistant Acid Phosphatase 5b Activity Secreted into the Culture Medium
SL Alatalo, JM Halleen, TA Hentunen, J Mönkkönen, HK Väänänen |
Clinical chemistry | 2000 |
Annexin II increases osteoclast formation by stimulating the proliferation of osteoclast precursors in human marrow cultures
C Menaa, RD Devlin, SV Reddy, Y Gazitt, SJ Choi, GD Roodman |
Journal of Clinical Investigation | 1999 |
Cell biology of the osteoclast
GD Roodman |
Experimental Hematology | 1999 |
A putative role for c-Fos in the pathophysiology of paget's disease
KE Beedles, PT Sharpe, EF Wagner, AE Grigoriadis |
Journal of Bone and Mineral Research | 1999 |
Characterization of Immortalized Osteoclast Precursors Developed from Mice Transgenic for Both bcl-X L and Simian Virus 40 Large T Antigen 1
TA Hentunen, SH Jackson, H Chung, SV Reddy, J Lorenzo, SJ Choi, GD Roodman |
Endocrinology | 1999 |
Commitment and differentiation of stem cells to the osteoclast lineage
SI Hayashi, T Yamane, A Miyamoto, H Hemmi, H Tagaya, Y Tanio, H Kanda, H Yamazaki, T Kunisada |
Biochemistry and Cell Biology | 1998 |